Filing search / Mesa Laboratories, Inc. / "Pandemic"

8-K

EX-99.1

MLAB Mesa Laboratories, Inc.

3 Aug 23

Mesa Labs Announces First Quarter Results

8:00am

may be forward-looking statements, including statements relating to: the duration and impact of the COVID-19 pandemic and its adverse effects on our

8-K

EX-99.1

MLAB Mesa Laboratories, Inc.

25 May 23

Mesa Labs Announces Unaudited Fourth Quarter and Full Fiscal Year 2023 Results

8:00am

of historical fact may be forward-looking statements, including statements relating to: the duration and impact of the COVID-19 pandemic and its adverse

8-K

EX-99.1

MLAB Mesa Laboratories, Inc.

3 Nov 22

Mesa Labs Announces Second Quarter Results

8:01am

that are not statements of historical fact may be forward-looking statements, including statements relating to: the duration and impact of the COVID-19 pandemic

DEFA14A

io5f3tmfhd jn544

19 Aug 22

Additional proxy soliciting materials

7:54pm

8-K

EX-99.1

a4sqimga

4 Aug 22

Mesa Labs Announces First Quarter Results

8:00am

8-K

EX-99.1

4qpmh5

31 May 22

Mesa Labs Reports Fourth Quarter and Full Fiscal Year Results

8:00am

424B5

nkoq5vq yvkfibxs90c

5 Apr 22

Prospectus supplement for primary offering

4:39pm

S-3ASR

j03kv348fk49drtz4

5 Apr 22

Automatic shelf registration

4:07pm

8-K

EX-99.3

gfe2hl5ox z67eo

30 Mar 22

Condensed Consolidated Financial Statements

5:22pm

8-K

EX-99.1

zarypyb9q2ecm

3 Feb 22

Mesa Labs Announces Third Quarter Results

8:00am

8-K

EX-99.1

wvs11cxk747uiq28

4 Nov 21

Mesa Labs Announces Second Quarter Results

8:00am